Neural control of pancreatic peptide hormone secretion

Peptides. 2022 Jun:152:170768. doi: 10.1016/j.peptides.2022.170768. Epub 2022 Feb 18.

Abstract

Pancreatic peptide hormone secretion is inextricably linked to maintenance of normal levels of blood glucose. In animals and man, pancreatic peptide hormone secretion is controlled, at least in part, by input from parasympathetic (vagal) premotor neurons that are found principally in the dorsal motor nucleus of the vagus (DMV). Iatrogenic (insulin-induced) hypoglycaemia evokes a homeostatic response commonly referred to as the glucose counter-regulatory response. This homeostatic response is of particular importance in Type 1 diabetes in which episodes of hypoglycaemia are common, debilitating and lead to suboptimal control of blood glucose. Glucagon is the principal counterregulatory hormone but for reasons unknown, its secretion during insulin-induced hypoglycaemia is impaired. Pancreatic parasympathetic neurons are distinguishable electrophysiologically from those that control other (e.g. gastric) functions and are controlled by supramedullary inputs from hypothalamic structures such as the perifornical region. During hypoglycaemia, glucose-sensitive, GABAergic neurons in the ventromedial hypothalamus are inhibited leading to disinhibition of perifornical orexin neurons with projections to the DMV which, in turn, leads to increased secretion of glucagon.

Keywords: Glucagon; Glycaemia; Insulin; Pancreas; Parasympathetic.

MeSH terms

  • Animals
  • Blood Glucose
  • Glucagon
  • Glucose / adverse effects
  • Humans
  • Hypoglycemia*
  • Insulin / pharmacology
  • Insulins* / adverse effects

Substances

  • Blood Glucose
  • Insulin
  • Insulins
  • Glucagon
  • Glucose